Bulletin
Investor Alert

New York Markets Close in:

Market Snapshot Winners and Losers

Teva Pharmaceutical Industries Ltd. ADR

NYS: TEVA

GO

Set Alerts

Market Index

Overview Profile Charts Financials Historical Quotes Analyst Estimates Options SEC Filings Insiders
/marketstate/country/us
Teva Pharmaceutical Industries Ltd. ADR

Market open

TEVA
/zigman2/quotes/205657894/composite

$

7.52

Change

+0.14 +1.83%

Volume

Volume 5.05m

Jun 8, 2023, 10:12 a.m.

Real time quotes

/zigman2/quotes/205657894/composite

Previous close

$ 7.38

$ 7.52

Change

+0.14 +1.83%

Day low

Day high

$7.49

$7.65

Open
Open: 7.51

52 week low

52 week high

$6.78

$11.45

Open

Market cap

$8.26B

Average volume

13.51M

P/E ratio

N/A

Rev. per Employee

$405,800

EPS

-1.44

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/teva

MarketWatch News on TEVA

  3. Teva Will Slim Down Its Generic Drug Business

    3:22 p.m. May 18, 2023

    - Barron's Online

  5. Why this might be a good time to buy junk bonds

    8:35 a.m. April 29, 2023

    - Philip van Doorn

  10. Teva names former Sandoz chief Richard Francis as new CEO

    8:16 a.m. Nov. 21, 2022

    - Steve Gelsi

  11. Teva Pharmaceutical names pharma exec Richard Francis and president and CEO

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  12. New Teva CEO Richard Francis was CEO of Sandoz and Biogen exec

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  13. Teva CEO Kåre Schultz to retire on Dec. 31

    8:05 a.m. Nov. 21, 2022

    - Steve Gelsi

  14. Teva Pharmaceutical downgraded to underweight from neutral at J.P. Morgan

    7:45 a.m. Nov. 14, 2022

    - Tomi Kilgore

  15. Teva Is 'on the Way' to Leaving Opioid Litigation Behind, CEO Says

    12:28 p.m. Nov. 3, 2022

    - Barron's Online

  19. Teva Pharmaceutical upgraded to buy from neutral at BofA Securities

    9:44 a.m. Aug. 5, 2022

    - Tomi Kilgore

  21. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/teva

Other News on TEVA

  1. 10-Q: TEVA PHARMACEUTICAL INDUSTRIES LTD

    4:11 p.m. May 10, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  2. Students Struggle Academically, Fight Amid Adderall Shortage

    2:34 a.m. March 25, 2023

    - The Wall Street Journal Interactive Edition

  3. McKinsey Consulted VA While Advising Opioid Makers to Target Agency for Sales

    2:32 a.m. March 14, 2023

    - The Wall Street Journal Interactive Edition

  4. Francisco Garcia Parames' Cobas Funds 4th-Quater Letter

    6:01 p.m. Feb. 22, 2023

    - GuruFocus.com

  5. Top 5 4th Quarter Trades of BECK MACK & OLIVER LLC

    7:00 a.m. Feb. 18, 2023

    - GuruFocus.com

  6. Top 5 4th Quarter Trades of MILLER VALUE PARTNERS, LLC

    1:00 a.m. Feb. 18, 2023

    - GuruFocus.com

  7. Top 5 3rd Quarter Trades of Exor Capital LLP

    3:00 p.m. Feb. 16, 2023

    - GuruFocus.com

  8. Top Trades of David Abrams' Firm in the 4th Quarter

    4:54 p.m. Feb. 13, 2023

    - GuruFocus.com

  9. Opioid Settlement Money Is Coming. Two Ohio Counties Differ on How to Spend It.

    9:08 a.m. June 5, 2023

    - The Wall Street Journal Interactive Edition

  10. 10-K: TEVA PHARMACEUTICAL INDUSTRIES LTD

    8:06 a.m. Feb. 10, 2023

    - Edgar Online - (EDG = 10Q, 10K)

  11. Humira Faces Competition From First U.S. Copycat

    1:40 p.m. June 5, 2023

    - The Wall Street Journal Interactive Edition

  12. DEA Pressed ADHD-Drug Makers About Impact of Telehealth Firms on Surging Demand

    11:20 a.m. Dec. 31, 2022

    - The Wall Street Journal Interactive Edition

  14. World’s Top-Selling Drug Going Off Patent Means Big Bucks for Middlemen

    4:21 a.m. Nov. 28, 2022

    - The Wall Street Journal Interactive Edition

  16. Teva Pharmaceutical Names Richard Francis as CEO

    3:32 a.m. Nov. 22, 2022

    - The Wall Street Journal Interactive Edition

  17. Top 5 3rd Quarter Trades of DSC Advisors, L.P.

    9:00 a.m. Nov. 15, 2022

    - GuruFocus.com

/news/pressrelease/company/us/teva

Press Releases on TEVA

  1. Teva Launches New “Pivot to Growth” Strategy

    8:30 a.m. May 18, 2023

    - BusinessWire - BZX

  7. Teva to Launch New Growth Strategy at Investor Day

    8:35 a.m. April 27, 2023

    - BusinessWire - BZX

Rates »

Mortgage Equity Savings Auto
Link to MarketWatch's Slice.